TREVI THERAPEUTICS INC (TRVI)

US89532M1018 - Common Stock

4.07  -0.25 (-5.79%)

After market: 4.07 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
48.22M33.92M29.91M32.48M32.49M
Research and Development
36.57M23.68M19.83M22.98M22.33M
Selling, General, and Administrative Expenses
11.65M10.24M10.07M9.49M10.16M
Operating Income
-48.22M-33.92M-29.91M-32.48M-32.49M
Interest Income/Expense
3.89M4.36M430.00K-1.11M-290.00K
Other Income/Expense
-20.00K469.00K290.00K-380.00KN/A
Income Before Taxes
-44.35M-29.10M-29.19M-33.96M-32.78M
Income Tax
-29.00K-32.00K-40.00K-20.00K-20.00K
Net Income
-44.32M-29.07M-29.15M-33.94M-32.76M
EBITDA
-48.07M-33.80M-29.87M-32.43M-32.44M
 
Per Share Data
EPS Diluted Total Ops
-0.44-0.29-0.45-1.49-1.81
Non GAAP EPS
-0.44-0.29-0.56-1.52-1.81
 
Statistics

All data in USD

Charts